Insights On Manufacturing Logistics

  1. FAQs On The Revised EU GMP Annex 1: Volume 7 2/4/2026

    Modernize your sterile manufacturing approach. Explore essential insights on contamination control strategies, risk management, and barrier technologies to ensure full regulatory alignment.

  2. FAQs On The Revised EU GMP Annex 1: Volume 8 2/4/2026

    Successfully implementing a site-wide CCS requires prioritizing barrier technologies, integrating primary packaging into risk assessments, and adopting a data-driven approach to environmental monitoring.

  3. Lyophilization: Protecting And Preserving Biologics 2/4/2026

    Discover how lyophilization revolutionizes biologic drug manufacturing and ensures potent, stable treatments for complex diseases.

  4. Consistent, Reliable, High-Quality Components 2/3/2026

    Discover a premium line of components for vials, prefilled syringes, and cartridge systems developed and refined to provide best-in-class levels of quality, performance, and risk mitigation.

  5. Evolving Methods Of Bulk Freezing 1/29/2026

    Learn how the transition to plate-based freezing with single-use technologies improves scalability and contamination control while ensuring uniform thermal transfer for high-value bulk drug substances.

  6. A Trusted New Partnership 1/28/2026

    Optima delivers high‑quality, flexible syringe and vial filling solutions with fast qualification, U.S.‑based support, and long‑term partnership reliability, helping CDMOs scale efficiently and confidently.

  7. Handling Demanding Active Ingredients Safely And Efficiently 1/27/2026

    See three flexible Optima fill‑finish and syringe assembly systems to boost performance, accuracy, and scalability, enabling efficient processing of diverse formats and supporting rapid CDMO growth.

  8. How Reshoring, GLP-1s, And Supply Chain Security Are Transforming CDMOs 1/23/2026

    Explore how reshoring, GLP-1 capacity demands, and integrated U.S.-based manufacturing models are reshaping CDMO partnerships in a rapidly evolving pharmaceutical market.

  9. The Role Of Primary Packaging In At‑Home Drug Products 1/21/2026

    Selecting primary packaging for biologics requires evaluating formulation type, administration route, dosing needs, and stability to ensure safe, effective, home‑use‑ready drug products.

  10. Sterile Filling Readiness In The Drug Device Delivery Ecosystem 1/14/2026

    Explore how adaptable technologies and strategic partnerships help navigate Annex 1 compliance and technical hurdles to ensure the successful delivery of complex drug products.